The pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms of diseases caused by infectious agents. Treatment of visceral leishmaniasis (VL) with the first licensed of an antileishmanial drug in the United States.
При низкой оригинальности работы "Editorial response: U.S. food and drug administration approval of ambisome (liposomal amphotericin b) for treatment of visceral leishmaniasis", Вы можете повысить уникальность этой работы до 80-100%
